References:
1. Cooper Jr LT, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis—natural history and treatment. New England Journal of Medicine.1997;336(26):1860-1866.
2. Fallon JM, Parker AM, Dunn SP, Kennedy JL. A giant mystery in giant cell myocarditis: navigating diagnosis, immunosuppression, and mechanical circulatory support.ESC heart failure. 2020;7(1):316-320.
3. Meyer T, Grumbach IM, Kreuzer H, Morguet AJ. Giant cell myocarditis due to coxsackie B2 virus infection. Cardiology. 1997;88(3):296-299.
4. Xu J, Brooks EG. Giant cell myocarditis: a brief review. Archives of pathology & laboratory medicine. 2016;140(12):1429-1434.
5. Mele D, Flamigni F, Rapezzi C, Ferrari R. Myocarditis in COVID-19 patients: current problems. Internal and Emergency Medicine. 2021:1-7.
6. Rathore SS, Rojas GA, Sondhi M, et al. Myocarditis associated with Covid-19 disease: A systematic review of published case reports and case series.International Journal of Clinical Practice. n/a(n/a):e14470.
7. Shi S, Qin M, Cai Y, et al. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. European heart journal. 2020;41(22):2070-2079.
8. Yang F, Cao S, Liu X, Xiang Y, Zhao Q. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. European Heart Journal. 2020;41:2070-2079.
9. Blagova O, Ainetdinova D, Sedov A, et al. Progressive chronic SARS‐CoV‐2‐positive giant cell myoendocarditis with atrial standstill and sudden cardiac death.ESC Heart Failure. 2021.
10. Agdamag ACC, Edmiston JB, Charpentier V, et al. Update on COVID-19 myocarditis.Medicina. 2020;56(12):678.
11. Blauwet LA, Cooper LT. Myocarditis. Progress in cardiovascular diseases.2010;52(4):274-288.
12. Ramandi MMA, Yarmohammadi H, Beikmohammadi S, et al. Comparison of the cardiovascular presentations, complications and outcomes following different coronaviruses’ infection: A systematic review. Journal of Cardiovascular and Thoracic Research. 2021;13(2):92-101.
13. Bang V, Ganatra S, Shah SP, et al. Management of Patients With Giant Cell Myocarditis.Journal of the American College of Cardiology.2021;77(8):1122-1134.
14. Cooper Jr LT, Hare JM, Tazelaar HD, et al. Usefulness of immunosuppression for giant cell myocarditis. The American journal of cardiology.2008;102(11):1535-1539.
15. Ekström K, Räisänen‐Sokolowski A, Lehtonen J, Nordenswan HK, Mäyränpää MI, Kupari M. Idiopathic giant cell myocarditis or cardiac sarcoidosis? A retrospective audit of a nationwide case series. ESC heart failure. 2020;7(3):1362-1370.
16. Kandolin R, Lehtonen J, Salmenkivi K, Räisänen-Sokolowski A, Lommi J, Kupari M. Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression. Circulation: Heart Failure. 2013;6(1):15-22.
17. Baykal Selcuk L, Sahin M, Arıca DA, Orem A, Karaca Ural Z, Yaylı S. Impairment of myocardial functions and arterial stiffness in patients with lichen planus☆,☆☆.Anais brasileiros de dermatologia. 2020;95:180-186.
18. Gonzalez JG, Marcus MD, Santa Cruz DJ. Giant cell lichenoid dermatitis. Journal of the American Academy of Dermatology. 1986;15(1):87-92.
19. Goldberg LJ, Goldberg N, Abrahams I, Silvers DN, Szaniawski W, Halperin AJ. Giant cell lichenoid dermatitis: A possible manifestation of sarcoidosis. Journal of Cutaneous Pathology. 1994;21(1):47-51.
20. Birnie DH, Nair V, Veinot JP. Cardiac Sarcoidosis and Giant Cell Myocarditis: Actually, 2 Ends of the Same Disease? Journal of the American Heart Association. 2021;10(6):e020542.
21. Jiang GY, Cai Q, Grandin EW, Sabe MA. Fulminant cardiac sarcoidosis resembling giant cell myocarditis: a case report. European Heart Journal - Case Reports. 2021;5(3).
22. Nordenswan HK, Lehtonen J, Ekström K, et al. Manifestations and outcome of cardiac sarcoidosis and idiopathic giant cell myocarditis by 25‐year nationwide cohorts.Journal of the American Heart Association. 2021;10(6):e019415.
23. Okura Y, Dec GW, Hare JM, et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. Journal of the American College of Cardiology. 2003;41(2):322-329.
24. Schaller T, Hirschbühl K, Burkhardt K, et al. Postmortem examination of patients with COVID-19.Jama. 2020;323(24):2518-2520.
25. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. The Lancet. 2020;395(10234):1417-1418.
26. Diaz GA, Parsons GT, Gering SK, Meier AR, Hutchinson IV, Robicsek A. Myocarditis and pericarditis after vaccination for COVID-19. JAMA. 2021.
27. Hudson B, Mantooth R, DeLaney M. Myocarditis and pericarditis after vaccination for COVID‐19.Journal of the American College of Emergency Physicians Open.2021;2(4).